MedPath

Exploring the use of optical coherence tomography and hyperspectral imaging in glioma detection during surgery

Recruiting
Conditions
glioma
10029211
10009720
Registration Number
NL-OMON44150
Lead Sponsor
eurochirurgie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
6
Inclusion Criteria

glioma and planned surgery

Exclusion Criteria

Histopathological diagnoses is not glioma

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Comparison of average spectrum of tumour tissue and healthy brain (cortical and<br /><br>subcortical) for HSI.<br /><br>Comparison of image characteristics of tumour tissue and healthy brain<br /><br>(cortical and subcortical) for OCT.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>In each dataset (HSI and OCT) clusters of characteristics will be examined that<br /><br>result in most efficient detection of tumour tissue.</p><br>
© Copyright 2025. All Rights Reserved by MedPath